Business

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FF

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FF

articleSinocelltech Group Limited Class ASeptember 2, 20243/news/announcement-on-voluntary-disclosure-of-obtaining-notice-of-approval-for-drug-clinical-trial-of-holding-subsidiarys-product-sct520ff
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FF

About this update from Sinocelltech Group Limited Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Holding Subsidiary's Product SCT520FFThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinocelltech Group Limited Class A